Efficacy of Antidepressants in Animal Models of Ischemic Stroke
- 1 October 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 45 (10), 3055-3063
- https://doi.org/10.1161/strokeaha.114.006304
Abstract
Background and Purpose—Poststroke depression is a prevalent complication of stroke with unclear pathogenesis. The benefits of antidepressants in this context and their effects on stroke recovery other than effects on mood are not clearly defined, with some studies suggesting efficacy in improving functional outcome in both depressed and nondepressed stroke patients. We have analyzed the preclinical animal data on antidepressant treatment in focal cerebral ischemia, modeled±depression, to help inform clinical trial design. Methods—We performed a systematic review and meta-analysis of data from experiments testing the efficacy of antidepressants versus no treatment to reduce infarct volume or improve neurobehavioral or neurogenesis outcomes in animal models of stroke. We used random-effects metaregression to test the impact of study quality and design characteristics and used trim and fill to assess publication bias. Results—We identified 44 publications describing the effects of 22 antidepressant drugs. The median quality checklist score was 5 of a possible 10 (interquartile range, 4–7). Overall, antidepressants reduced infarct volume by 27.3% (95% confidence interval, 20.7%–33.8%) and improved neurobehavioral outcomes by 53.7% (46.4%–61.1%). There was little evidence for an effect of selective serotonin reuptake inhibitors on infarct volume. For neurobehavioral outcomes there was evidence of publication bias. Selective serotonin reuptake inhibitors were the most frequently studied antidepressant subtype and improved neurobehavioral outcome by 51.8% (38.6%–64.9%) and increased neurogenesis by 2.2 SD (1.3–3.0). Conclusions—In line with current clinical data and despite some limitations, antidepressant treatments seem to improve infarct volume and neurobehavioral outcome in animal models of ischemic stroke.This publication has 27 references indexed in Scilit:
- Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic strokeSystematic Reviews, 2013
- Effect of Antidepressants on the Course of Disability Following StrokeAmerican Journal of Geriatric Psychiatry, 2011
- Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trialThe Lancet Neurology, 2011
- Chronic Fluoxetine Stimulates Maturation and Synaptic Plasticity of Adult-Born Hippocampal Granule CellsJournal of Neuroscience, 2008
- The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behaviorBehavioural Pharmacology, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2005
- Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication BiasStroke, 2004
- Fluoxetine modulates motor performance and cerebral activation of patients recovering from strokeAnnals of Neurology, 2001
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986